Follow us on:
Breaking News
20-10-2026
Breaking News
Breaking News

Cellares, SNUH Partner on Cell Therapy Manufacturing

 
Cellares, SNUH Partner on Cell Therapy Manufacturing

The partners will evaluate Cellares’ Cell Shuttle for scalable manufacturing of a gene-modified PNH therapy.
Read More >>

test

Sponsored Videos

Cohance Lifesciences: A Global CDMO Platform with Multi-Modality Expertise

Small Molecules. ADCs. Nucleic Acid Chemistry.

Friday Brief
Videos

The Friday Brief for August 28, 2026: A Week of Multi-Billion Dollar Deals

Werewolf and Ambros are merging, and McKesson is acquiring Precision Medicine Group.

Breaking News
Collaborations & Alliances

ExploRNA, Łukasiewicz Research Network Partner on GMP Manufacturing of Next-Gen mRNA Cap Analogs

Łukasiewicz, known for advanced chemical synthesis and production scaling capabilities, will help ExploRNA ramp up its mRNA manufacturing.

Breaking News
Promotions & Moves

Travere Therapeutics Names Bradley Campbell CEO

Former Amicus Therapeutics CEO Bradley Campbell will succeed Eric Dube on Dec. 1, 2026.

Breaking News
Promotions & Moves

Mirum Pharmaceuticals Names Rob Myers Chief Medical Officer

Myers comes from OrsoBio, where he was Chief Medical Officer as well as Head of Development.

Featured Resources

Solution Content Center SPOTLIGHT

Vetter Pharma International

Vetter is a leading and independent global CDMO for the aseptic production of injectables. Its roots and headquarters are in Ravensburg, Germany. Vetter has been a stable, reliable family-owned company since its establishment as a pharmacy in 1950, now with more than 7,400 skilled and dedicated employees.

 

Solution Content Center SPOTLIGHT

IDT Biologika

IDT Biologika is a global CDMO for vaccines, recombinant proteins, viral vectors, gene & immune therapeutics, monoclonal antibodies, oncolytic viruses and other sterile injectables. End-to-end services in process development, drug substance manufacturing, fill&finish, packaging, quality control and analytics.